Erivedge (vismodegib) — United Healthcare
Medulloblastoma
Initial criteria
- Diagnosis of medulloblastoma
- Patient has mutations in the sonic hedgehog pathway
- Patient has failed prior chemotherapy
Reauthorization criteria
- Patient does not show evidence of progressive disease while on Erivedge therapy
Approval duration
12 months